top of page

Detailed Post 

Navigating the FDA's Guidelines for Variations in Pharmaceuticals

This post contains a list of links giving access to the most relevant variation guidance published by FDA.

 



Guidance "Changes to an approved NDA or ANDA"



Guidance "Changes to an Approved NDA or ANDA: Questions and Answers"


Guidance "CMC Postapproval Manufacturing Changes To Be Documented in Annual Reports"



Draft Guidance "CMC Postapproval Manufacturing Changes for Specified Biological Products To Be Documented in Annual Reports" Link



Guidance "Postapproval Changes to Drug Substances"



Guidance "Variations in Drug Products that May Be Included in a Single ANDA"



Guidance "PAC-ATLS: Postapproval Changes - Analytical Testing Laboratory Sites"



Guidance "Changes to an Approved Application for Specified Biotechnology and Specified Synthetic Biological Products" (link)



Guidance "Changes to an Approved Application: Biological Products" Link





Comments


logo apsyos

Our Address

Talk To our Experts

Email Us

We are located near Basel

Thanks for subscribing!

Apsyos

As Health is the main priority in our lives, it is important that patients get the most appropriate and safe treatments in the fastest and most reliable way without compromising of its quality.

About

​Apsyos offers small and medium pharmaceutical and biologic manufacturers the freedom to focus their internal capacities towards Science and Clinical Concerns by alleviating technical regulatory aspects.

We are operating from London and Basel

Map

©2021 par Apsyos. Créé avec Wix.com.

About Us   Services   Privacy

J2 RA CMC Services Ltd, 128 City Road EC1V 2NX, London, United Kingdom

Registered Company Nr: 16260386

bottom of page